Jason L Gaglia MD

Diabetes, Lipid Metabolism, Parathyroid, Thyroid

Assistant Professor, Joslin Diabetes Center

1 Joslin PlRoom 470Boston, MA 02215
Phone+1 617-732-2675
Fax+1 617-732-2452

Dr. Gaglia is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gaglia's full profile Already have an account?

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2003 - 2006
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2001 - 2003
Harvard Medical SchoolClass of 2001

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2021 - Present
MA State Medical License 2006 - 2027
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011, 2013, 2015, 2017
CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011, 2013, 2015, 2017
CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2012

Clinical Trials

Imaging of Type 1 Diabetes Progression
UNKNOWN
Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus
COMPLETED
PHASE2
Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes
COMPLETED
NA

Publications & Presentations

PubMed

Real-World Total Daily Insulin Dose in over 14,000 Young Individuals with Type 1 Diabetes in the United States.
Rebecca L Molinsky, Jason Gaglia, Yumin Zhang, Tina Gupta, Saketh Rompicherla
Diabetes Technology & Therapeutics. 2026-05-12
Hospital-Treated Severe Hypoglycemia in Type 1 Diabetes in the US: A Retrospective Claims-Based Study of Diabetes-Related Complications and Direct Medical Costs.
Adriana Boateng-Kuffour, Nanxin Li, Keval Chandarana, Vamshi Ruthwik Anupindi, Liang Chen
Advances in Therapy. 2026-04-01
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.
Carla J Greenbaum, S Alice Long, Stephen E Gitelman, Jason L Gaglia, Mark Daniels
Diabetes. 2026-03-01